Xuwang Chen

883 total citations
27 papers, 789 citations indexed

About

Xuwang Chen is a scholar working on Infectious Diseases, Virology and Organic Chemistry. According to data from OpenAlex, Xuwang Chen has authored 27 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 14 papers in Virology and 12 papers in Organic Chemistry. Recurrent topics in Xuwang Chen's work include HIV/AIDS drug development and treatment (20 papers), HIV Research and Treatment (14 papers) and Click Chemistry and Applications (7 papers). Xuwang Chen is often cited by papers focused on HIV/AIDS drug development and treatment (20 papers), HIV Research and Treatment (14 papers) and Click Chemistry and Applications (7 papers). Xuwang Chen collaborates with scholars based in China and Belgium. Xuwang Chen's co-authors include Xinyong Liu, Peng Zhan, Erik De Clercq, Dongyue Li, Christophe Pannecouque, Zengjun Fang, Jan Balzarini, Xiao Li, Ye Tian and Xin Liu and has published in prestigious journals such as European Journal of Medicinal Chemistry, Current Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Xuwang Chen

27 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuwang Chen China 16 437 403 294 202 167 27 789
Zengjun Fang China 19 558 1.3× 560 1.4× 402 1.4× 288 1.4× 390 2.3× 27 1.2k
Maha Kosa United States 6 282 0.6× 315 0.8× 170 0.6× 80 0.4× 284 1.7× 9 837
Waleed A. Zalloum Jordan 15 216 0.5× 252 0.6× 164 0.6× 64 0.3× 281 1.7× 34 697
Charles A. Flentge United States 9 445 1.0× 233 0.6× 303 1.0× 101 0.5× 212 1.3× 14 738
Samantha Zanoli Italy 15 244 0.6× 279 0.7× 193 0.7× 101 0.5× 233 1.4× 23 618
Richard Hazen United States 20 879 2.0× 441 1.1× 687 2.3× 275 1.4× 516 3.1× 36 1.5k
Cheng-Kon Shih United States 13 681 1.6× 348 0.9× 595 2.0× 162 0.8× 337 2.0× 16 1.1k
Lianhong Xu United States 18 231 0.5× 378 0.9× 146 0.5× 71 0.4× 270 1.6× 42 920
Christer Sahlberg Sweden 14 290 0.7× 375 0.9× 221 0.8× 89 0.4× 209 1.3× 33 708
T. MIYASAKA Japan 10 364 0.8× 167 0.4× 278 0.9× 117 0.6× 220 1.3× 25 572

Countries citing papers authored by Xuwang Chen

Since Specialization
Citations

This map shows the geographic impact of Xuwang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuwang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuwang Chen more than expected).

Fields of papers citing papers by Xuwang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuwang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuwang Chen. The network helps show where Xuwang Chen may publish in the future.

Co-authorship network of co-authors of Xuwang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xuwang Chen. A scholar is included among the top collaborators of Xuwang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuwang Chen. Xuwang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Wang, Yanyan, Rui Zhang, Pingli Li, et al.. (2017). The Development and Validation of the Accurate and Sensitive HPLC Method for Quantification of Mizoribine in Human Plasma and Its Clinical Applications. Current Pharmaceutical Analysis. 14(6). 541–546. 1 indexed citations
4.
Chen, Xuwang, Dongwei Kang, Boshi Huang, et al.. (2016). Design, synthesis and evaluation of novel HIV-1 NNRTIs with dual structural conformations targeting the entrance channel of the NNRTI binding pocket. European Journal of Medicinal Chemistry. 115. 53–62. 21 indexed citations
5.
Chen, Xuwang, Yuanyuan Li, Jan Balzarini, et al.. (2013). Discovery of Piperidine‐Linked Pyridine Analogues as Potent Non‐nucleoside HIV‐1 Reverse Transcriptase Inhibitors. ChemMedChem. 8(7). 1117–1126. 15 indexed citations
6.
Zhang, Lingzi, Peng Zhan, Xuwang Chen, et al.. (2013). Design, synthesis and preliminary SAR studies of novel N-arylmethyl substituted piperidine-linked aniline derivatives as potent HIV-1 NNRTIs. Bioorganic & Medicinal Chemistry. 22(1). 633–642. 21 indexed citations
7.
Chen, Xuwang, Xin Liu, Qing Meng, et al.. (2013). Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(24). 6593–6597. 21 indexed citations
8.
Song, Yuning, Peng Zhan, Dongwei Kang, et al.. (2013). Discovery of novel pyridazinylthioacetamides as potent HIV-1 NNRTIs using a structure-based bioisosterism approach. MedChemComm. 4(5). 810–810. 8 indexed citations
9.
Rai, Diwakar, Wen‐Ming Chen, Ye Tian, et al.. (2013). Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIs. Bioorganic & Medicinal Chemistry. 21(23). 7398–7405. 11 indexed citations
10.
Chen, Xuwang, et al.. (2013). Recent Advances of Diaryl Ether Family as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors. Current Pharmaceutical Design. 19(15). 2829–2838. 12 indexed citations
11.
Zhan, Peng, Xiao Li, Zhenyu Li, et al.. (2012). Structure-based bioisosterism design, synthesis and biological evaluation of novel 1,2,4-triazin-6-ylthioacetamides as potent HIV-1 NNRTIs. Bioorganic & Medicinal Chemistry Letters. 22(23). 7155–7162. 48 indexed citations
12.
Zhan, Peng, Wen‐Ming Chen, Zhenyu Li, et al.. (2012). Discovery of novel 2-(3-(2-chlorophenyl)pyrazin-2-ylthio)-N-arylacetamides as potent HIV-1 inhibitors using a structure-based bioisosterism approach. Bioorganic & Medicinal Chemistry. 20(23). 6795–6802. 15 indexed citations
13.
Zhan, Peng, Liu Wang, Hong Liu, et al.. (2012). Arylazolyl(azinyl)thioacetanilide. Part 9: Synthesis and biological investigation of thiazolylthioacetamides derivatives as a novel class of potential antiviral agents. Archives of Pharmacal Research. 35(6). 975–986. 14 indexed citations
14.
Chen, Xuwang, Peng Zhan, Christophe Pannecouque, et al.. (2012). Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors. European Journal of Medicinal Chemistry. 51. 60–66. 48 indexed citations
15.
Zhan, Peng, et al.. (2012). Benzimidazole Heterocycle as a Privileged Scaffold in Antiviral Agents. Mini-Reviews in Organic Chemistry. 9(4). 397–410. 20 indexed citations
16.
Li, Xiao, Peng Zhan, Hong Liu, et al.. (2012). Arylazolyl(azinyl)thioacetanilides. Part 10: Design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors. Bioorganic & Medicinal Chemistry. 20(18). 5527–5536. 17 indexed citations
17.
Chen, Xuwang, Peng Zhan, Xin Liu, et al.. (2012). Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry. 20(12). 3856–3864. 66 indexed citations
18.
Zhan, Peng, Xuwang Chen, Xiao Li, et al.. (2011). Arylazolylthioacetanilide. Part 8☆: Design, synthesis and biological evaluation of Novel 2-(2-(2,4-Dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides As Potent HIV-1 inhibitors. European Journal of Medicinal Chemistry. 46(10). 5039–5045. 32 indexed citations
19.
Chen, Xuwang, Peng Zhan, Dongyue Li, Erik De Clercq, & Xinyong Liu. (2011). Recent Advances in DAPYs and Related Analogues as HIV-1 NNRTIs. Current Medicinal Chemistry. 18(3). 359–376. 90 indexed citations
20.
Zhan, Peng, Dongyue Li, Xuwang Chen, Xinyong Liu, & Erik De Clercq. (2010). Functional Roles of Azoles Motif in Anti-HIV Agents. Current Medicinal Chemistry. 18(1). 29–46. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zengjun Fang Breakdown of academic impact, for papers by Maha Kosa Breakdown of academic impact, for papers by Waleed A. Zalloum Breakdown of academic impact, for papers by Charles A. Flentge Breakdown of academic impact, for papers by Samantha Zanoli Breakdown of academic impact, for papers by Richard Hazen Breakdown of academic impact, for papers by Cheng-Kon Shih Breakdown of academic impact, for papers by Lianhong Xu Breakdown of academic impact, for papers by Christer Sahlberg Breakdown of academic impact, for papers by T. MIYASAKA
Rankless by CCL
2026